XPH vs. BBH: Healthcare ETF Comparison Highlights Key Metrics
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowThe State Street SPDR S&P Pharmaceuticals ETF (XPH) features a broader portfolio with 65 holdings compared to the 25 biotechnology leaders of the VanEck Biotech ETF (BBH). Both funds have identical annual expense ratios of 0.35% and yield 0.50%. Over the past year, total returns have significantly diverged, with XPH offering less volatility. This information is crucial for investors seeking stable, diversified exposure in the healthcare sector, especially given the consistent demand for medical products regardless of economic conditions.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About State Street Corporation (STT)
State Street is a major custodian bank and asset manager behind the SPDR ETFs.
The Financials sector covers banks, insurers and capital-markets firms at the center of the economy.
Earlier STT news
- KBE vs IAT: Expense Ratio Comparison Highlights Financial Sector ETFs
- SPDW vs VWO: Key Metrics for International ETF Investors
- SPY vs. QQQ: ETF Analysis for 2026 Investment Decisions
- State Farm (STT) AI Plan for Sales Agents Sparks Major Discussion
- VTI vs SPTM ETF Comparison: Performance, Costs, and Holdings
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
